scholarly journals Are immunosuppressant related to unfavorable outcomes in patients COVID-19 with autoimmune rheumatic disease?: A review of clinical evidence

2022 ◽  
Vol 49 (1) ◽  
pp. 5-14
Author(s):  
Oki Nugraha Putra ◽  
Hardiyono Hardiyono ◽  
Mia Arum Anggraini
Keyword(s):  
Rheumatic Disease ◽  
Clinical Evidence ◽  
Autoimmune Rheumatic Disease

Vitamin D and autoimmune rheumatic disease

2015 ◽  
Vol 11 (6) ◽  
pp. 333-334 ◽  
Author(s):  
Mario García-Carrasco ◽  
José Luis Gálvez Romero
Keyword(s):  
Vitamin D ◽  
Rheumatic Disease ◽  
Autoimmune Rheumatic Disease

scholarly journals Prevalence and clinical impact of systemic autoimmune rheumatic disease in patients with silicosis

2021 ◽  
Author(s):  
José Jesús Blanco-Pérez ◽  
Victoria Arnalich-Montiel ◽  
Ángel Salgado-Barreira ◽  
María Angel Alvarez-Moure ◽  
Adriana Carolina Caldera-Díaz ◽  
...  
Keyword(s):  
Rheumatic Disease ◽  
Clinical Impact ◽  
Autoimmune Rheumatic Disease ◽  
Systemic Autoimmune Rheumatic Disease

Systemic sclerosis and related disorders

2011 ◽  
pp. 363-384
Author(s):  
Alan J. Hakim ◽  
Gavin P.R. Clunie ◽  
Inam Haq
Keyword(s):  
Systemic Sclerosis ◽  
Rheumatic Disease ◽  
Diagnostic Criteria ◽  
Rare Disorders ◽  
Microvascular Damage ◽  
Autoimmune Rheumatic Disease

Epidemiology and diagnostic criteria 364 Cutaneous features of scleroderma and their treatment 368 Systemic features of the disease, investigation, and treatment 372 Antifibrotic and immunosuppressive therapies for systemic sclerosis 378 Summary—the approach to systemic sclerosis 380 Scleroderma-like fibrosing disorders 382 • Scleroderma is a spectrum of rare disorders ranging from limited to generalized, non-systemic to systemic, and environmental to autoimmune rheumatic disease. Generalized scleroderma, systemic sclerosis, predominantly affects women and is associated with production of collagen, widespread microvascular damage, and inflammation....

Sign in / Sign up

Export Citation Format

Share Document